Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03KTK
|
||||
Former ID |
DIB013256
|
||||
Drug Name |
TAK-937
|
||||
Synonyms |
Cerebroprotectant (acute stroke, injection), Takeda; CB1/CB2 receptor agonist (acute stroke, injection), Takeda
|
||||
Indication | Cerebrovascular ischaemia [ICD9: 434.91; ICD10:I61-I63] | Discontinued in Phase 1 | [548963] | ||
Company |
Takeda Pharmaceutical Co Ltd
|
||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 2 | Target Info | Modulator | [531715] | |
Cannabinoid receptor 1 | Target Info | Modulator | [531715] | ||
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.